Skip to main content
curacle co., ltd. logo

curacle co., ltd. — Investor Relations & Filings

Ticker · 365270 ISIN · KR7365270008 KO Professional, scientific and technical activities
Open in API
Filings indexed 203 across all filing types
Latest filing 2023-08-29 Regulatory Filings
Country KR South Korea
Listing KO 365270

About curacle co., ltd.

http://www.curacle.com/eng/main/

Curacle Co., Ltd. is a clinical-stage biopharmaceutical company focused on the research and development of innovative drugs for intractable vascular diseases. The company's core platform technology centers on developing highly effective protectors against endothelial dysfunction, a key factor in various age-related and vascular conditions. Its development pipeline includes novel treatments targeting significant unmet medical needs, with a particular focus on conditions such as Diabetic Macular Edema (DME), Wet Age-related Macular Degeneration (wet AMD), diabetes, and stroke. Curacle aims to create differentiated therapies through innovative targets and treatment concepts, including the development of orally administered medications for complex eye diseases.

Recent filings

Filing Released Lang Actions
투자판단관련주요경영사항(임상시험계획승인신청)(CU06-1004 국내 1b상 임상시험 계획(IND) 신청)
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from Curacle regarding the submission of an Investigational New Drug (IND) application for a Phase 1b clinical trial. It follows the standard format for 'Major Management Matters' (투자판단 관련 주요경영사항) in the Korean market, which is used to disclose significant operational updates such as clinical trial progress. Since it does not fit into specific categories like M&A, dividends, or financial reports, and is a formal regulatory disclosure, it is classified as a Regulatory Filing (RNS).
2023-08-29 Korean
반기보고서 (2023.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-annual Report) for the company 'Curacle' covering the period from January 1, 2023, to June 30, 2023. It contains detailed company information, business operations, financial data, and management discussions, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2023
2023-08-11 Korean
투자판단관련주요경영사항(임상시험계획승인신청)(중증도 내지 중증 궤양성 대장염에 대한 CU104 의 제2상 임상시험계획승인신청(IND))
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from a Korean company (Curacle) regarding a 'Major Management Matter' (투자판단 관련 주요경영사항), specifically the application for approval of a Phase 2 clinical trial (IND). This type of disclosure is a standard regulatory announcement for material corporate events in the Korean market. Since it does not fit into specific categories like financial reports, dividends, or M&A, it falls under the general regulatory filing category.
2023-07-17 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding the issuance of convertible bonds (전환사채권 발행결정) by Curacle (큐라클). It details the terms of the bond issuance, including interest rates, conversion prices, put/call options, and the list of investors. This type of filing is a standard regulatory disclosure for capital raising activities in the Korean market, which falls under the 'Capital/Financing Update' category.
2023-06-28 Korean
증권발행결과(자율공시)(제1회차 CB)
Share Issue/Capital Change Classification · 100% confidence The document is a formal announcement regarding the results of a securities issuance (specifically a convertible bond, or CB). It details the issuance method, amount, and payment date. This falls under the category of capital and financing updates, specifically related to the issuance of debt instruments.
2023-06-28 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) from Curacle, specifically detailing the issuance of convertible bonds (전환사채권 발행결정). It outlines the terms of the financing, including interest rates, conversion prices, put/call options, and the list of investors. This falls under the category of company fundraising and financing activities.
2023-06-26 Korean

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.